cancer

Why breast cancer spreads to bone

Researchers from Tampere University, Finland, and Izmir Institute of Technology, Turkey, have developed an in vitro cancer model to investigate…

2 years ago

Do people with MS have an increased risk of cancer?

A new study has found some cancers to be slightly more frequent in people with multiple sclerosis (MS) than in…

2 years ago

Drug improves effectiveness of radiation for lung cancer that has spread to the brain

In new research, a team led by University of Cincinnati researchers has identified a potential new way to make radiation…

2 years ago

New cancer diagnoses did not rebound as expected following pandemic

Cancer incidence trends in 2021 largely returned to what they were before the COVID-19 pandemic, according to a study by…

2 years ago

Clinical trial successfully repurposes cancer drug for hereditary bleeding disorder

A drug approved for treating the blood cancer multiple myeloma may offer a safe and effective way to reduce the…

2 years ago

Study links neighborhood environment to prostate cancer risk in men with West African genetic ancestry

West African genetic ancestry was associated with increased prostate cancer among men living in disadvantaged neighborhoods but not among men…

2 years ago

Antibody-drug conjugate found effective against brain metastases in patients with HER2-positive breast cancer

A drug that delivers chemotherapy directly to tumors has shown impressive activity against some of the hardest-to-reach cancer cells: those…

2 years ago

Experimental mRNA cancer vaccine shows potential for advanced stage cancer patients in Phase 1 trial

Interim data from the Phase I dose escalation part of the mRNA cancer immunotherapy (mRNA-4359), show promise in patients with…

2 years ago

Drug developed for pancreatic cancer shows promise against most aggressive form of medulloblastoma

A drug that was developed to treat pancreatic cancer has now been shown to increase symptom-free survival in preclinical medulloblastoma…

2 years ago

Tumor-infiltrating lymphocyte therapy marks a milestone in cancer treatment

The recent U.S. Food and Drug Administration approval of lifileucel, the first commercial tumor-infiltrating lymphocyte (TIL) therapy for advanced melanoma,…

2 years ago